Parexel has published findings and recommendations for making clinical research more accessible and welcoming for transgender and nonbinary people.
While there are nearly 1.6 million transgender people in the US alone, of the thousands interventional clinical trial results published on PubMed from 2018 to 2022, Parexel notes less than one percent included participation of transgender and nonbinary patients. Many have deep-rooted reservations about healthcare and worry the risks of participating in a clinical trial would outweigh its benefits.
Through collaborating with partners and their patient advisory council and extensive research, Parexel identified five roadblocks to participation and eight solutions for designing more equitable clinical trials for transgender and nonbinary patients.
Download the study here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.